scholarly journals Maternal pomegranate juice intake and brain structure and function in infants with intrauterine growth restriction: A randomized controlled pilot study

PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0219596 ◽  
Author(s):  
Lillian G. Matthews ◽  
Christopher D. Smyser ◽  
Sara Cherkerzian ◽  
Dimitrios Alexopoulos ◽  
Jeanette Kenley ◽  
...  
2014 ◽  
Vol 26 (1) ◽  
pp. 150
Author(s):  
P. Peugnet ◽  
S. Valentino ◽  
A. Tarrade ◽  
L. Wimel ◽  
F. Reigner ◽  
...  

In equids, placentation is diffuse and the nutrient supply to the fetus is determined by uterine size, which is correlated with maternal size. The size of the mare affects fetal development as shown by embryo transfer (ET) between Ponies and Thoroughbreds. In turn, insulin sensitivity in the newborn foal and subsequent postnatal growth rate are affected. We enhanced or restricted fetal growth through ET using Pony (P), Saddlebred (S), and Draft (D) horses and investigated placental morphology, structure, and function at term. Control pregnancies of P-P (n = 21), S-S (n = 28), and D-D (n = 8) were obtained by AI. Enhanced and restricted pregnancies were obtained by transferring P (P-D, n = 6) and S embryos (S-D, n = 8) into D mares or S embryos into P mares (S-P, n = 6), respectively. Placental weight and surface were recorded at delivery. Samples were collected for stereology and RT-qPCR analysis of expression of genes involved in placental growth, vascularization, and nutrient transport. Housekeeping genes were RPL32, SCAMP3, and B2M. Data were analysed by Kruskal-Wallis followed by Dunn's post hoc test. Placental weight and surface were increased in S-S and in D-D compared with P-P, whereas S-S and D-D were not different. No histological changes were observed among controls, but most genes had their expression decreased in P-P compared with S-S and D-D. The P-D foals had a 57% increased birthweight with heavier and larger placentas than P-P foals. The S-D foals were similar to both S-S and D-D in terms of birthweight and placental weight and surface. No major modifications in placental histology or transcript levels were observed in both enhanced groups. In contrast, S-P foals had a 37% decreased birthweight with lighter and smaller placentas compared with S-S and S-D foals. There was no gross histological difference between S-P and S-S but the microcotyledonary surface density was higher in S-P compared with S-D. Moreover, the expression of IGF2, IGF2R, SLC2A1, and eNOS was decreased in S-P compared with S-S. There was no difference in gene expression between S-P and P-P. In conclusion, intrauterine growth restriction led to marked changes in placental morphology, histology, and gene expression. The increased microcotyledonary surface density suggests a lengthening of villi, which could increase feto-maternal contact surface as a compensatory mechanism for the restricted uterine capacity. Surprisingly, placental adaptation to the restricted intrauterine environment in S-P induced gene profiles resembling that of control P, whereas no difference was observed in enhanced pregnancies.


2016 ◽  
Vol 11 (6) ◽  
pp. 1652-1663 ◽  
Author(s):  
D. D. Correa ◽  
J. C. Root ◽  
M. Kryza-Lacombe ◽  
M. Mehta ◽  
S. Karimi ◽  
...  

Blood ◽  
2019 ◽  
Vol 134 (Supplement_1) ◽  
pp. 1121-1121
Author(s):  
Ahmad Al-Huniti ◽  
Lyndsay A Harshman ◽  
Marci Novak ◽  
Peggy Nopoulos ◽  
Janice M Staber

Introduction: Bleeding resulting from factor VIII deficiency (hemophilia A) can occur in any tissue including the brain. While significant progress has been made in prevention and treatment of hemophilia-related joint and muscle disease with prophylaxis, there is a paucity of research to understand, treat, or prevent brain disease in hemophilia patients. People with hemophilia are recognized to be at risk for neuropsychiatric and neurocognitive disorders even when treated with factor VIII (FVIII) primary prophylaxis. This is especially problematic given that brain injury is difficult to detect early, and consequences are often delayed. Therefore, our study aims to evaluate brain structure and cognitive function in pediatric patients with severe FVIII deficiency in order to improve outcomes. Methods: After IRB approval, a single-center pilot study enrolled seven pediatric subjects with severe FVIII deficiency and 23 healthy controls to evaluate brain structure and function. Inclusion criteria included males aged 6 - 16 years. All subjects with severe hemophilia A had a FVIII level of less than 1% completed at the Iowa Hemophilia and Thrombosis Center. Any subject was excluded due to a known diagnosis of traumatic brain injury, brain tumor, major chromosomal anomalies, or intellectual disability. Subjects with a known diagnosis of intracranial hemorrhage or FVIII inhibitor were excluded. Neurocognitive assessments included the Behavioral Regulation Index of Executive Function (BRIEF) which measures executive function. Magnetic resonance imaging sequences included T1, T2, and diffusion tensor imaging. Freesurfer and Brain Research: Analysis of Images, Networks, and Systems (BRAINS2) software were used to preprocess imaging and generate volumetric data. Results: Mean age for PWH was 10.4 years and 11.8 years for controls (p = 0.24). Both groups had similar height, weight, and socioeconomic status. Despite normal IQ, PWH demonstrate impaired behavior regulation and globally impaired executive composition compared to controls (p = 0.001 and p = 0.038, respectively). Volumetric brain quantification revealed subjects with hemophilia had decreased whole brain volumes compared to controls (p = 0.019). Our analysis suggests that these differences are in discrete regions. Future analysis will investigate if volumetric differences correlate with neurocognitive assessments. Conclusions: PWH demonstrated abnormal brain structure and function compared to healthy controls. Further evaluation is warranted to understand why and how FVIII deficiency and its treatment alter neurological outcomes. Disclosures Staber: UniQure: Honoraria; Genentech: Honoraria; Bayer: Honoraria; Spark: Honoraria; Novo Nordisk: Honoraria.


2017 ◽  
Vol 49 (5S) ◽  
pp. 824 ◽  
Author(s):  
X. r. Tan ◽  
Ivan C. C. Low ◽  
Mary C. Stephenson ◽  
T. Kok ◽  
Heinrich W. Nolte ◽  
...  

2011 ◽  
Vol 32 (6) ◽  
pp. 814-822 ◽  
Author(s):  
Linda L. Chao ◽  
Linda Abadjian ◽  
Jennifer Hlavin ◽  
Deiter J. Meyerhoff ◽  
Michael W. Weiner

Sign in / Sign up

Export Citation Format

Share Document